Skip to content
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

ADVERTISE WITH US | EMAIL: KROX@RRV.NET

diabetes

news

Red Cross of ND and NW Minnesota offering free A1C testing to donors in March

March is Red Cross Month, and to celebrate the eastern North Dakota and northwestern Minnesota American Red Cross is offering free A1C testing for blood donors in March. Access to health screenings like A1C testing helps individuals take steps toward a healthier future. “We want to empower people with valuable health insights while ensuring a […]

Share:
news

RIVERVIEW HEALTH NOW OFFERING MONOCLONAL ANTIBODY TREATMENT FOR HIGH RISK COVID-19 PATIENTS

RiverView Health is now offering monoclonal antibody treatment for those who have tested positive for COVID-19, are at high risk for progressing to severe COVID-19, and have certain risk factors, such as diabetes or heart disease that increases their risk of severe COVID-19 complications. This one-time, one-hour outpatient IV infusion treatment has proven to reduce

Share: